NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for American Society of Clinical Oncology


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Researchers from UC Irvine Medical Center Find Clinical Advantages to Using RapidArc(R) Radiotherapy for the Stereotactic Treatment of Tumors
2009 NOV 23 ... the UCI Department of Radiation Oncology, in a presentation at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Chicago.(1) "The reduction in ... that image-guided RapidArc=AE radiotherapy from Varian Medical Systems (NYSE:VAR) has clinical advantages over earlier fixed-beam approaches to stereotactic radiosurgery (SRS) or ...
Subject: Varian Medical Systems, Inc.
Price: $3.00
*
Scientists at University of Ghent target breast cancer
2009 NOV 23 ... Publisher contact information for the journal Molecular and Cellular Biology is: American Society Microbiology, 1752 N St. NW, Washington, DC 20036-2904, USA. ... and paracrine growth factor, which promotes angiogenesis, metastasis, and subversion of immunity, and changes the response to hormones and to chemotherapeutics. We explored ... Women's Health, University of Ghent. This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2009, Clinical Oncology ...
Subject: Breast Cancer
Price: $3.00
*
SNM applauds House action to build medical isotopes reactor in the US
2009 NOV 23 ... SNM applauds the U.S. House of Representatives for its passage of H.R. 3276-the American Medical Isotopes Production Act of 2009. "The worldwide isotope shortage ... Cancer, Diagnostics, Heart Disease, Nuclear Medicine, Oncology, Thyroid Disease, Society of Nuclear Medicine. This article was prepared by Clinical Oncology Week ...
Subject: Society of Nuclear Medicine
Price: $3.00
*
Studies conducted at E.J. Jacobs et al on pancreatic cancer recently published
2009 NOV 23 ... Control, 2009;20(8):1261-1269). For more information, contact E.J. Jacobs, American Cancer Society, Dept. of Epidemiology Epidemiology & Surveillance Research, National ... Netherlands. Keywords: City:Atlanta, State:GA, Country:United States, Clinical Trial Research, Epidemiology, Gastroenterology, Oncology, Pancreas, Pancreatic Cancer, ...
Subject: Pancreatic Cancer
Price: $3.00
*
Studies from C. Sorrentino and colleagues yield new information about inflammation
2009 NOV 23 ... prognostic indicator." Sorrentino and colleagues published their study in American Journal of Respiratory and Critical Care Medicine (Expression of IL-32 in Human Lung ... for the American Journal of Respiratory and Critical Care Medicine is: American Thoracic Society, 1740 Broadway, New York, NY 10019-4374, USA. Keywords: City:Chieti, ... in Chieti, Italy report. "Lung cancer subtypes display different clinical outcomes. We have set out to clarify the role of IL-32 in the physiopathology of the ... Enzymes, Infectious Disease, Inflammation, Lung Cancer, Lung Neoplasms, Microscopy, Oncology, Polymerase, Pulmonology, Respiratory Infection, Squamous Cell Carcinoma, Therapy, ...
Subject: Inflammation
Price: $3.00
*
Studies from G. Cavaletti and co-researchers in the area of inflammation published
2009 NOV 23 ... The publisher of the journal Molecular Pharmaceutics can be contacted at: American Chemical Society, 1155 16th St., NW, Washington, DC 20036, USA. Keywords: ... EAE but not in healthy rats. The overall binding efficacy paralleled the severity of the clinical score, but targeting was observed already before clinical manifestation of inflammation. ... Molecular Therapies, Multiple Sclerosis, Neuroimmunology, Neuroinflammation, Neurology, Oncology, Pharmaceuticals, Therapy, Treatment, Tumor Vascularization. This article ...
Subject: Inflammation
Price: $3.00
*
Studies from J.B. Mascarenhas et al further understanding of cancer
2009 NOV 23 ... The publisher's contact information for the Journal of Biological Chemistry is: American Society Biochemistry Molecular Biology Inc., 9650 Rockville Pike, Bethesda, MD ... Proteins, Proteomics, Tyrosine Kinase. This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2009, Clinical Oncology ...
Subject: Cancer
Price: $3.00
*
Studies from P.E. Teloken and colleagues provide new data on renal cell carcinoma
2009 NOV 23 ... defined as metastasis or death from disease, adjusting for age, sex, operation type, American Society of Anesthesiologists score, TNM stage and tumor size. Of 1,863 patients 1,333 ... was 3.4 years. On univariate analysis patients with clear cell histology had a worse clinical outcome. Five-year probability of freedom from metastasis or death from disease was 86% ... Country:United States, Gastroenterology, Genetics, Histology, Kidney, Nephrology, Oncology, Pathology, Renal Cell Cancer, Renal Cell Carcinoma, Urology. This article ...
Subject: Renal Cell Carcinoma
Price: $3.00
*
Studies in the area of enzyme research reported from D. Niiya and co-researchers
2009 NOV 23 ... The publisher of the Journal of Biological Chemistry can be contacted at: American Society Biochemistry Molecular Biology Inc., 9650 Rockville Pike, Bethesda, MD ... Oncology, Physiology, Proteins, Proteomics. This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2009, Clinical Oncology ...
Subject: Enzyme Research
Price: $3.00
*
Study data from University of Copenhagen provide new insights into human papillomavirus vaccines
2009 NOV 23 ... The publisher of the journal Cancer Prevention Research can be contacted at: American Association Cancer Research, 615 Chestnut St., 17TH Floor, Philadelphia, PA 19106-4404, ... of Copenhagen, Rigshospitalet, Dept. of Virus Hormones & Cancer, Danish Cancer Society, Institute Cancer Epidemiology, DK-2100 Copenhagen, Denmark. The publisher ... high-grade cervical, vaginal, and vulvar lesions based on end-of-study data from three clinical trials," investigators in Copenhagen, Denmark report. "Additionally, we ... Research, DNA, Gynecology, HPV Vaccines, Human Papillomavirus Vaccines, Immunization, Oncology, Ovarian Cancer, Ovarian Carcinoma, Vaccination, Vaccine Efficacy, Vulvar Disease, ...
Subject: Human Papillomavirus Vaccines
Price: $3.00
*
Study data from University of Paris update understanding of cancer
2009 NOV 23 ... The publisher's contact information for the journal Molecular Pharmaceutics is: American Chemical Society, 1155 16th St., NW, Washington, DC 20036, USA. Keywords: ... is an anticancer nucleoside analogue active against a wide variety of solid tumors. However, following intravenous administration, this drug is rapidly ... tumor model in mice. To further establish the candidature of this nanomedicine for clinical trials, in this communication we have tested the preclinical efficacy of squalenoyl ... Immunosuppressant, Molecular Pharmacology, Molecular Therapies, Nucleoside Analog, Oncology, Pharmaceuticals, Pre-Trials Research, Radiation-Sensitizing Agent, Solid Cancers, Solid ...
Subject: Cancer
Price: $3.00
*
Study findings from Medical College of Wisconsin provide new insights into breast cancer therapy
2009 NOV 23 ... over the past 20 years. Based on clinical trial results, AI use is recommended by the American Society of Clinical Oncology for treatment of postmenopausal women with HR+ breast cancer," scientists writing in ...
Subject: Breast Cancer Therapy
Price: $3.00
*
Study results from University of Florida, Department of Community Health provide new insights into breast cancer therapy
2009 NOV 23 ... they received on cancer-related side-effects, including race-specific information. The American Society of Clinical Oncology's breast cancer survivorship care plan was viewed as important, but too highly ...
Subject: Breast Cancer Therapy
Price: $3.00
*
Study results from Y. Xia et al provide new insights into pancreatic cancer
2009 NOV 23 ... Publisher contact information for the Journal of Medicinal Chemistry is: American Chemical Society, 1155 16th St., NW, Washington, DC 20036, USA. Keywords: ... effects. This compound did not inhibit DNA synthesis and therefore does not resemble the clinical drug gemcitabine," wrote Y. Xia and colleagues. The researchers concluded: ... Anticancer Therapy, Apoptosis, Drug Development, Gastroenterology, Medicinal Chemistry, Oncology, Pancreas, Pancreatic Cancer, Pancreatic Neoplasms, Therapy, Treatment. ...
Subject: Pancreatic Cancer
Price: $3.00
*
Tokai Pharmaceuticals Initiates ARMOR Clinical Development Program for TOK-001; First Ever Multi-Target Investigational Drug for Prostate Cancer
2009 NOV 23 ... information. About Castration Resistant Prostate Cancer (CRPC) According to the American Cancer Society, prostate cancer is the most frequently diagnosed cancer among men in the ... focused on developing new treatments for prostate cancer, announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the treatment of patients ... Philip Kantoff, M.D., chief clinical research officer, chief, division of solid tumor oncology, and director, Lank Center for Genitourinary Oncology at the Dana-Farber Cancer ...
Subject: Tokai Pharmaceuticals
Price: $3.00
*
Trubion Announces Acceptance of Two Presentations on Its TRU-016 Product Candidate at the 2009 ASH Annual Meeting
2009 NOV 23 ... the acceptance of two data presentations on its product candidate, TRU-016, at the 2009 American Society of Hematology (ASH) Annual Meeting Dec. 5-8, 2009 in New Orleans, Louisiana. The ... The presentations will include additional positive data from 1) an ongoing Phase 1 clinical trial of TRU-016 for the treatment of chronic lymphocytic leukemia (CLL), and 2) a ... N. Morial Convention Center) Keywords: Trubion Pharmaceuticals, Inc., Oncology, Chronic Lymphocytic Leukemia, Hematology, Clinical Trial Research, Clinical Trials, ...
Subject: Trubion Pharmaceuticals, Inc.
Price: $3.00
*
UB study explores how women make decisions about breast cancer surgery
2009 NOV 23 ... cancer will affect one in every eight women in the United States, according to the American Cancer Society, causing them to have to decide quickly about treatment. ... For women just diagnosed with breast cancer, one of the important decisions confronting them is whether to have a lumpectomy or mastectomy. ... Women's Health, University at Buffalo. This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2009, Clinical Oncology ...
Subject: University at Buffalo
Price: $3.00
*
United Brings Bear Hugs and Smiles for Miles and Miles
2009 NOV 23 ... United Airlines and the American Cancer Society® are teaming up for the third consecutive year, inviting individuals ... money and miles to benefit children with cancer. Holden is the cuddly younger brother of Maye I. Hugyou and Kenny Hugyou, who delivered smiles to nearly 18,000 children in 2008 ... Cancer, Oncology, Pediatrics, United Airlines. This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2009, Clinical Oncology ...
Subject: United Airlines
Price: $3.00
*
ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society
2009 NOV 23 ... in lymphoma, particularly peripheral T-cell lymphoma ("PTCL"), were reported at the American Society of Clinical Oncology (ASCO) in May. Supported by these data, the Company expects to advance into a ...
Subject: ZIOPHARM Oncology, Inc.
Price: $3.00
*
ZIOPHARM Reports Third Quarter Financial Results and Updated Clinical Progress
2009 NOV 23 ... in lymphoma, particularly peripheral T-cell lymphoma ("PTCL"), were reported at the American Society of Clinical Oncology (ASCO) in May. Supported by these data, the Company expects to advance into a ...
Subject: ZIOPHARM Oncology, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login